Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MD HPLC, MD Mass Spec, and Software Receive IVDD CE-Marking

By LabMedica International staff writers
Posted on 15 Sep 2015
The in vitro diagnostics device (IVDD) CE marking for the two high-performance instruments and software enables a combined system with the high accuracy of LC-MS to now be available to clinical laboratories in Europe for general IVD use.

Thermo Fisher Scientific (Waltham, MA, USA) has received the CE marking for its Thermo Scientific Prelude MD HPLC, Endura MD mass spectrometer, and ClinQuan MD software. More...
Clinical laboratories in Europe now have access to a high-performance liquid chromatograph, mass spectrometer, and LC-MS software designed and manufactured for analyzing patient samples as components of laboratory-developed IVD tests.

"We're strongly committed to bringing the advantages of LC-MS to the clinical market," said Bradley Hart, strategic director, life sciences mass spectrometry, clinical markets, Thermo Fisher, “These three products are part of a larger initiative to make mass spectrometry more useful and accessible to clinicians.”

The Prelude MD HPLC provides automated sample cleanup and two channels of HPLC separation for greater productivity and certainty from laboratory-developed clinical diagnostic tests. Developing IVD tests with the Endura MD MS provides excellent sensitivity, quantitative performance, and robustness with built-in usability to help deliver more value and worry-free results.

The products were exhibited at the 2nd Annual European Conference on Clinical Mass Spectrometry, MSACL EU 2015 (September 8-11, Salzburg, Austria).

Related Links:

Thermo Fisher Scientific
Thermo Fisher Posters & Products presented at MSACL EU 2015
MSACL EU 2015 Conference 



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.